Litigation
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al.
dismissed1:22-cv-02229-MKV
- Filed
- 2022-03-18
- Terminated
- 2023-08-07
Patents at issue (1)
Plaintiffs (1)
Defendants (2)
Summary
Acuitas filed a declaratory-judgment action against Genevant and Arbutus in the Southern District of New York concerning Comirnaty; US 8,822,668 was among the patents at issue. The action was voluntarily dismissed without prejudice on August 4, 2023, and Acuitas refiled in New Jersey.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
In the news
What the press has reported about this case, summarized with links to the source articles.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).